Gul Halise Inci, Yamali Cem, Yesilyurt Fatma, Sakagami Hiroshi, Kucukoglu Kaan, Gulcin Ilhami, Gul Mustafa, Supuran Claudiu T
a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Ataturk University , Erzurum , Turkey.
b Division of Pharmacology , Meikai University School of Dentistry , Sakado , Saitama , Japan.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):369-374. doi: 10.1080/14756366.2016.1254207.
In this study, 4-[5-(4-hydroxyphenyl)-3-aryl-4,5-dihydro-1H-pyrazol-1-yl]benzenesulfonamide derivatives (8-14) were synthesized for the first time by microwave irradiation and their chemical structures were confirmed by H NMR, C NMR and HRMS. Cytotoxic activities and inhibitory effects on carbonic anhydrase I and II isoenzymes of the compounds were investigated. The compounds 9 (PSE = 4.2), 12 (PSE = 4.1) and 13 (PSE = 3.9) with the highest potency selectivity expression (PSE) values in cytotoxicity experiments and the compounds 13 (Ki = 3.73 ± 0.91 nM toward hCA I) and 14 (Ki = 3.85 ± 0.57 nM toward hCA II) with the lowest Ki values in CA inhibition studies can be considered as leader compounds for further studies.
在本研究中,首次通过微波辐射合成了4-[5-(4-羟基苯基)-3-芳基-4,5-二氢-1H-吡唑-1-基]苯磺酰胺衍生物(8-14),并通过氢核磁共振、碳核磁共振和高分辨质谱对其化学结构进行了确证。研究了这些化合物的细胞毒性活性以及对碳酸酐酶I和II同工酶的抑制作用。在细胞毒性实验中具有最高效选择性表达(PSE)值的化合物9(PSE = 4.2)、12(PSE = 4.1)和13(PSE = 3.9),以及在碳酸酐酶抑制研究中具有最低Ki值的化合物13(对人碳酸酐酶I的Ki = 3.73 ± 0.91 nM)和14(对人碳酸酐酶II的Ki = 3.85 ± 0.57 nM)可被视为进一步研究的先导化合物。